Skip to main content

Open Access Rapid assessment of the demand and supply of tobacco dependence pharmacotherapy in Uganda

Tobacco dependence pharmacotherapy (TDP) plays a major role in smoking cessation. We conducted a rapid assessment of current smoking, availability of TDP and the willingness to quit and to pay for TDP among 56 patients with tobacco-attributable diseases and 38 pharmacies in Uganda. Of the 56 patients, 63% were current smokers, 77.4% wanted to quit and 37% were willing to pay. Drugs were largely unavailable: nicotine replacement products were available in only seven pharmacies (18%) and bupropion in three (8%); these cost respectively US$15.7 and US$17.1 for a 1-month supply. Improving supplies and lowering prices could facilitate access to TDP in Uganda.

Keywords: Uganda; pharmacotherapy; tobacco dependence

Document Type: Research Article

Affiliations: 1: Division of Pulmonary Medicine, Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda, Lung Institute, Makerere University College of Health Sciences, Kampala, Uganda 2: Lung Institute, Makerere University College of Health Sciences, Kampala, Uganda, Peninsula Medical School, University of Plymouth, Plymouth, UK 3: Lung Institute, Makerere University College of Health Sciences, Kampala, Uganda 4: International Primary Care Respiratory Group, Edinburgh, UK

Publication date: 21 March 2016

This article was made available online on 17 February 2016 as a Fast Track article with title: "Rapid assessment of the demand and supply of tobacco dependence pharmacotherapy in Uganda".

More about this publication?
  • Public Health Action (PHA), The Union's quarterly Open Access journal, welcomes the submission of articles on operational research. It publishes high-quality scientific research on health services, providing new knowledge on how to improve access, equity, quality and efficiency of health systems and services.

    The Editors will consider any manuscript reporting original research on quality improvements, cost-benefit analysis, legislation, training and capacity building, with a focus on all relevant areas of public health (e.g. infection control, nutrition, TB, HIV, vaccines, smoking, COVID-19, microbial resistance, outbreaks etc).

  • Editorial Board
  • Information for Authors
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content